Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Sell
57
-21
-27% -$10.6K ﹤0.01% 145
2026
Q1
$39K Sell
78
-7
-8% -$3.3K ﹤0.01% 134
2025
Q4
$36K Hold
85
﹤0.01% 138
2025
Q3
$40K Sell
85
-6
-7% -$2.84K ﹤0.01% 135
2025
Q2
$43K Sell
91
-18
-17% -$8.22K ﹤0.01% 127
2025
Q1
$51K Buy
109
+89
+445% +$40.1K ﹤0.01% 120
2024
Q4
$8K Buy
+20
New +$9.11K ﹤0.01% 121
2022
Q1
Sell
-1,500
Closed -$520K 206
2021
Q4
$520K Hold
1,500
0.01% 153
2021
Q3
$440K Hold
1,500
0.01% 172
2021
Q2
$434K Hold
1,500
0.01% 175
2021
Q1
$420K Buy
1,500
+400
+36% +$104K ﹤0.01% 167
2020
Q4
$271K Buy
+1,100
New +$270K ﹤0.01% 131

Other funds holding LIN

Clal Insurance's LIN Position: Q2 2026 in Review

Clal Insurance reduced its Linde (LIN) stake by 27% in Q2 2026, selling an estimated $10.6K and leaving 57 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #145.

Clal Insurance first reported a position in LIN in Q4 2020 and has held it in 12 quarters since. The position peaked at $520K in Q4 2021. 2,343 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Clal Insurance held 57 shares of Linde worth $30K as of Q2 2026.
  • Clal Insurance sold 21 Linde shares in Q2 2026, an estimated $10.6K.
  • Linde made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #145 holding.
  • Clal Insurance first reported a position in Linde in Q4 2020 and has held it in 12 quarters since.
  • Clal Insurance's Linde position peaked at $520K in Q4 2021.
  • 2,343 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.